MRC PHRU Medical Statistician
Charlie is a Medical Statistician within both the Renal Studies Group and Vascular Overviews Group at the Clinical Trials Service Unit & Epidemiology Studies Unit (CTSU). He joined CTSU in 2015 after working as an analyst within the NHS using routine healthcare data. Charlie completed his undergraduate degree in Economics at the University of East Anglia and MSc in Economics at Bristol University. His current research interests include the use and application of routine healthcare data within observational studies and randomized clinical trials.
He is also currently undertaking a part-time DPhil within the CTSU funded by the MRC Hubs for Trials Methodology Research (MRC HTMR). Charlie aims to investigate whether routine healthcare data can be used as the primary source of follow-up for clinical trials.
Can routine healthcare data be used to efficiently and reliably follow-up participants in renal trials? Analyses using linked data from 2 large renal trials.
Dr Natalie Staplin, Dr Will Herrington, Professor Martin Landray and Professor Colin Baigent
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group None., (2021), Lancet, 397, 605 - 612
Accelerometer-measured physical activity and functional behaviours among people on dialysis
Nawab K. et al, (2020), Clinical Kidney Journal
Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy.
Storey BC. et al, (2018), Kidney Int, 93, 1165 - 1174
Biliary Tract and Liver Complications in Polycystic Kidney Disease.
Judge PK. et al, (2017), J Am Soc Nephrol, 28, 2738 - 2748